JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Antitcoagulant and antiplatelet activities of scolymoside
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : BMB Reports
  • Volume 48, Issue 10,  2015, pp.577-582
  • Publisher : Korean Society for Biochemistry and Molecular Biology
  • DOI : 10.5483/BMBRep.2015.48.10.044
 Title & Authors
Antitcoagulant and antiplatelet activities of scolymoside
Yoon, Eun-Kyung; Ku, Sae-Kwang; Lee, Wonhwa; Kwak, Soyoung; Kang, Hyejin; Jung, Byeongjin; Bae, Jong-Sup;
  PDF(new window)
 Abstract
Cyclopia subternata is a medicinal plant commonly used in traditional medicine to relieve pain. Here, the anticoagulant effects of scolymoside, an active compound in C. subternata, were examined by monitoring activated partial thromboplastin time (aPTT), prothrombin time (PT), and the activities of thrombin and activated factor X (FXa). The effects of scolymoside on plasminogen activator inhibitor type 1 (PAI-1) and tissue-type plasminogen activator (t-PA) expression were evaluated in tumor necrosis factor (TNF)-α-activated human endothelial cells. Treatment with scolymoside resulted in prolonged aPTT and PT and the inhibition of thrombin and FXa activities and production. In addition, scolymoside inhibited thrombin-catalyzed fibrin polymerization and platelet aggregation. Scolymoside also elicited anticoagulant effects in mice, including a significant reduction in the PAI-1 to t-PA ratio. Collectively, these findings indicate that scolymoside possesses anticoagulant activities and could be developed as a novel anticoagulant.
 Keywords
Coagulation cascade;Endothelium;Fibrinolysis;Scolymoside;
 Language
English
 Cited by
1.
Inhibitory effects of pentacyclic triterpenoids from Astilbe rivularis on TGFBIp-induced inflammatory responses in vitro and in vivo, Chemico-Biological Interactions, 2016, 254, 179  crossref(new windwow)
2.
Inhibitory effects of three diketopiperazines from marine-derived bacteria on endothelial protein C receptor shedding in human endothelial cells and mice, Fitoterapia, 2016, 110, 181  crossref(new windwow)
3.
Anti-inflammatory effects of pelargonidin on TGFBIp-induced responses, Canadian Journal of Physiology and Pharmacology, 2016  crossref(new windwow)
4.
Suppressive effects of methylthiouracil on polyphosphate-mediated vascular inflammatory responses, Journal of Cellular and Molecular Medicine, 2016  crossref(new windwow)
5.
Ameliorative effect of a rarely occurring C-methylrotenoid on HMGB1-induced septic responses in vitro and in vivo, Biochemical Pharmacology, 2016, 110-111, 58  crossref(new windwow)
6.
Trimeric PEG-Conjugated Exendin-4 for the Treatment of Sepsis, Biomacromolecules, 2016, 17, 3, 1160  crossref(new windwow)
7.
Anti-inflammatory effects of dabrafenib on polyphosphate-mediated vascular disruption, Chemico-Biological Interactions, 2016, 256, 266  crossref(new windwow)
8.
Suppressive effects of three diketopiperazines from marine-derived bacteria on polyphosphate-mediated septic responses, Chemico-Biological Interactions, 2016, 257, 61  crossref(new windwow)
9.
Suppressive effects of lysozyme on polyphosphate-mediated vascular inflammatory responses, Biochemical and Biophysical Research Communications, 2016, 474, 4, 715  crossref(new windwow)
10.
Suppressive effects of three diketopiperazines from marine-derived bacteria on TGFBIp-mediated septic responses in human endothelial cells and mice, Archives of Pharmacal Research, 2016, 39, 6, 843  crossref(new windwow)
 References
1.
Prior RL and Cao G (1999) Antioxidant capacity and polyphenolic components of teas: implications for altering in vivo antioxidant status. Proc Soc Exp Biol Med 220, 255-261 crossref(new window)

2.
Warren CP (1999) Antioxidant effects of herbs. Lancet 353, 676 crossref(new window)

3.
Joubert E, Joubert ME, Bester C, De Beer D and De Lange JH (2011) Honeybush (Cyclopia spp.): From local cottage industry to global markets - The catalytic and supporting role of research. S A J Bot 77, 889-907

4.
Sanchez GM, Re L, Giuliani A, Nunez-Selles AJ, Davison GP and Leon-Fernandez OS (2000) Protective effects of Mangifera indica L. extract, mangiferin and selected antioxidants against TPA-induced biomolecules oxidation and peritoneal macrophage activation in mice. Pharmacol Res 42, 565-573 crossref(new window)

5.
Leiro JM, Alvarez E, Arranz JA, Siso IG and Orallo F (2003) In vitro effects of mangiferin on superoxide concentrations and expression of the inducible nitric oxide synthase, tumour necrosis factor-alpha and transforming growth factor-beta genes. Biochem Pharmacol 65, 1361-1371 crossref(new window)

6.
Pardo Andreu GL, Maurmann N, Reolon GK et al (2010) Mangiferin, a naturally occurring glucoxilxanthone improves long-term object recognition memory in rats. Eur J Pharmacol 635, 124-128 crossref(new window)

7.
Kazuno S, Yanagida M, Shindo N and Murayama K (2005) Mass spectrometric identification and quantification of glycosyl flavonoids, including dihydrochalcones with neutral loss scan mode. Anal Biochem 347, 182-192 crossref(new window)

8.
Palomo I, Fuentes E, Padro T and Badimon L (2012) Platelets and atherogenesis: Platelet anti-aggregation activity and endothelial protection from tomatoes (Solanum lycopersicum L.). Exp Ther Med 3, 577-584

9.
Roberfroid MB (2007) Inulin-type fructans: functional food ingredients. J Nutr 137, 2493S-2502S

10.
Hasler CM, Kundrat S and Wool D (2000) Functional foods and cardiovascular disease. Curr Atheroscler Rep 2, 467-475 crossref(new window)

11.
Philip-Joet F, Alessi MC, Philip-Joet C et al (1995) Fibrinolytic and inflammatory processes in pleural effusions. Eur Respir J 8, 1352-1356 crossref(new window)

12.
Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA Jr and Loskutoff DJ (1988) Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem 263, 5797-5803

13.
Hamaguchi E, Takamura T, Shimizu A and Nagai Y (2003) Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells. J Pharmacol Exp Ther 307, 987-994 crossref(new window)

14.
Davie EW (1995) Biochemical and molecular aspects of the coagulation cascade. Thromb Haemost 74, 1-6

15.
Davie EW, Fujikawa K and Kisiel W (1991) The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 30, 10363-10370 crossref(new window)

16.
Quinn C, Hill J and Hassouna H (2000) A guide for diagnosis of patients with arterial and venous thrombosis. Clin Lab Sci 13, 229-238

17.
Lopez S, Peiretti F, Bonardo B, Juhan-Vague I and Nalbone G (2000) Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells. Atherosclerosis 152, 359-366 crossref(new window)

18.
Lee KH (2000) Research and future trends in the pharmaceutical development of medicinal herbs from Chinese medicine. Public Health Nutr 3, 515-522 crossref(new window)

19.
Despotis GJ, Gravlee G, Filos K and Levy J (1999) Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. Anesthesiology 91, 1122-1151 crossref(new window)

20.
Jauch EC, Saver JL, Adams HP Jr et al (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44, 870-947 crossref(new window)

21.
Wells PS, Forgie MA and Rodger MA (2014) Treatment of venous thromboembolism. JAMA 311, 717-728 crossref(new window)

22.
Hirsh J, Raschke R, Warkentin TE, Dalen JE, Deykin D and Poller L (1995) Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 108, 258S-275S crossref(new window)

23.
Pereira MS, Melo FR and Mourao PA (2002) Is there a correlation between structure and anticoagulant action of sulfated galactans and sulfated fucans? Glycobiology 12, 573-580 crossref(new window)

24.
Lee W, Yoo H, Ku SK, Kim JA and Bae JS (2013) Anticoagulant activities of piperlonguminine in vitro and in vivo. BMB Rep 46, 484-489 crossref(new window)

25.
Ku SK and Bae JS (2014) Antiplatelet and antithrombotic activities of purpurogallin in vitro and in vivo. BMB Rep 47, 376-381 crossref(new window)

26.
Ku SK and Bae JS (2014) Antithrombotic activities of sulforaphane via inhibiting platelet aggregation and FIIa/FXa. Arch Pharm Res 37, 1454-1463 crossref(new window)

27.
Kim SY, Kim S, Kim JM et al (2011) PKC inhibitors RO 31-8220 and Go 6983 enhance epinephrine-induced platelet aggregation in catecholamine hypo-responsive platelets by enhancing Akt phosphorylation. BMB Rep 44, 140-145 crossref(new window)

28.
Nowak P, Zbikowska HM, Ponczek M, Kolodziejczyk J and Wachowicz B (2007) Different vulnerability of fibrinogen subunits to oxidative/nitrative modifications induced by peroxynitrite: functional consequences. Thromb Res 121, 163-174 crossref(new window)

29.
Bae JS, Lee W, Nam JO, Kim JE, Kim SW and Kim IS (2014) Transforming Growth Factor beta-induced Protein Promotes Severe Vascular Inflammatory Responses. Am J Respir Crit Care Med 189, 779-786 crossref(new window)

30.
Ku SK, Han MS, Lee MY, Lee YM and Bae JS (2014) Inhibitory effects of oroxylin A on endothelial protein C receptor shedding in vitro and in vivo. BMB Rep 47, 336-341 crossref(new window)

31.
Bae JS (2011) Antithrombotic and profibrinolytic activities of phloroglucinol. Food Chem Toxicol 49, 1572-1577 crossref(new window)

32.
Kim TH, Ku SK and Bae JS (2012) Antithrombotic and profibrinolytic activities of eckol and dieckol. J Cell Biochem 113, 2877-2883 crossref(new window)